Cancer stem cells in drug resistance:an introduction to the e-book covering the special issue on the“Cancer Stem Cells and Drug Resistance”  

作　　者：Balázs Sarkadi 

机构地区：[1]Institute of Enzymology,Research Centre for Natural Sciences,Budapest 1117,Hungary

出　　处：《Cancer Drug Resistance》2023年第2期239-241,共3页癌症耐药（英文）

摘　　要：A major problem in current cancer drug treatment is that a subset of cancer cells in many cases survives even highly efficient chemotherapy,and after a while,these remaining cells cause a recurrence of the disease.Moreover,the re-emerging cancer cells often show a multidrug-resistant phenotype,higher proliferation rate,higher invasiveness,and increased metastatic potential,as compared to original cancer.Cancer relapse and multidrug resistance are widely observed also in the most up-to-date,specifically targeted drug-or immunotherapies,causing an unsurmountable clinical inefficiency in cancer eradication.

关 键 词：CANCER DRUG CANCER 

分 类 号：R73-5[医药卫生—肿瘤] G23[医药卫生—临床医学]